e-ISSN: Pending
Negative / Null Result ReportOpen accessNeurology. Diseases of the nervous system

CSF neurofilament light chain but not FLT3 ligand discriminates Parkinsonian disorders

Megan Kristy Herbert; Marjolein B Aerts; Marijke eBeenes; Niklas eNorgren; Rianne A J Esselink; Bastiaan R Bloem; H Bea eKuiperij; Marcel M Verbeek · 2015 · Frontiers in Neurology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

The differentiation between multiple system atrophy (MSA) and Parkinson’s disease (PD) is difficult, particularly in early disease stages. Therefore, we aimed to evaluate the diagnostic value of neurofilament light chain (NFL), fms-like tyrosine kinase ligand (FLT3L) and total tau protein (t-tau) in cerebrospinal fluid (CSF) as biomarkers to discriminate MSA from PD. Using commercially available enzyme-linked immunoassays (ELISAs), we measured CSF levels of NFL, FLT3L and t-tau in a discovery cohort of 36 PD patients, 27 MSA patients and 57 non-neurological controls and in a validation cohort

Abstract by Megan Kristy Herbert; Marjolein B Aerts; Marijke eBeenes; Niklas eNorgren; Rianne A J Esselink; Bastiaan R Bloem; H Bea eKuiperij; Marcel M Verbeek, Frontiers in Neurology (2015) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.3389/fneur.2015.00091